Biogen Inc. buy Royal Bank of Canada
Start price
25.06.25
/
50%
€108.75
Target price
25.06.26
€183.16
Performance (%)
0.92%
Price
17:44
€109.75
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is nearly unchanged. This prediction currently runs until 25.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.045% | -0.045% |
| iShares Core DAX® | -0.933% | 0.936% |
| iShares Nasdaq 100 | -2.152% | 3.580% |
| iShares Nikkei 225® | 0.021% | 1.387% |
| iShares S&P 500 | -2.296% | 2.847% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $205.00 to $213.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat